/
Other
Sedation
75
Pipeline Programs↗
73
Active Trials↗
22
Companies Involved↗
Sedation is a moderately active landscape with 75 programs across 22 companies. The most active players are Merck & Co.. 11 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical63
Phase 1
No programs
Phase 311
Approved
No programs
Analysis
Trial Status
583
clinical trials
Completed337 · 58%
Unknown status112 · 19%
Recruiting44 · 8%
Terminated40 · 7%
Not yet recruiting21 · 4%
Withdrawn17 · 3%
Other12 · 2%
Clinical Trials
Trial Activity
583 trials
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
Recruiting·—·Phase 2/3·NCT04195256·400 enrolled
A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy
Recruiting·—·Phase 4·NCT07456111·90 enrolled
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)
Recruiting·—·Phase 4·NCT04916197·368 enrolled
Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients
Recruiting·—·Phase 4·NCT06575530·306 enrolled
Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness
Recruiting·—·N/A·NCT05823454·200 enrolled
Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy
Recruiting·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 3·NCT07184801·56 enrolled
Page 1 of 39
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)